I wrote a piece about the Trump Administration's plans to address drug prices, which was published on The CHOICE Institute Blog, Incremental Thoughts, on 16 May 2018. I summarized the key points from the Trump Administration and highlighted an interview by The CHOICE Institute alumnus, Dr. Jonathan H. Watanabe, Associated Professor of Clinical Pharmacy at the UCSD Skagg School of Pharmacy and Pharmaceutical Sciences. Dr. Watanabe argued that Medicare is unable to negotiate for lower prices like the U.S. Department of Veterans Affairs.
Dr. Watanabe's interview with NBC7 can be viewed here.
You can read my piece here.